Composition for treating sudden deafness or tinnitus and application thereof
By combining lidocaine and dexamethasone as acupoint injection, acupuncture of Tinggong point, Jiaosun point and Yifeng point, the problem of single efficacy in the treatment of sudden deafness and tinnitus in the prior art has been solved, and a significant improvement has been achieved The efficacy of treatment efficiency.
Patent Information
- Application Number
- CN202411125792.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art has a single effect in the treatment of sudden deafness and tinnitus, with no obvious effect, and the injection dose is not standardized, and there is no relevant record of combining lidocaine and dexamethasone for treatment.
Combine 20mg/ml lidocaine injection and 5mg/ml dexamethasone injection according to a volume ratio of 0.5:1, as acupoint injection, and penetrate the Tinggong point, Jiaosun point and Yifeng point through the skull breathing needle. Used to treat sudden deafness and tinnitus.
The treatment efficiency of sudden deafness and tinnitus has been significantly improved. The total treatment efficiency of sudden deafness has reached more than 78%, and the total treatment efficiency of tinnitus has reached more than 70%, which significantly improves or eliminates tinnitus and sudden deaf symptoms.
Smart Images

Figure BDA0004996361250000051 
Figure BDA0004996361250000071
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medicines, and in particular to a composition for treating sudden deafness or tinnitus and an application thereof. Background Art
[0002] The three most common symptoms of otolaryngology are tinnitus, deafness and vertigo, with tinnitus ranking first among the three symptoms. Tinnitus refers to the perception of one or more sounds produced without an external sound source. The incidence of tinnitus may increase with age, and its pathogenesis is relatively complex. With the increase in stress in modern people's lives, most studies have reported that tinnitus does not occur alone. People with tinnitus may experience ear stuffiness, ear pain, dizziness, and hearing loss, and the tinnitus will worsen over time. More than 50% of patients have sleep disorders, and the reduction in sleep quality exacerbates tinnitus. This vicious cycle will have a serious impact on the patient's quality of life.
[0003] Sudden deafness is an ear emergency that occurs suddenly within 72 hours, with unilateral hearing loss being the most common, and a hearing loss of ≥20dB in two consecutive frequencies. Most patients have no obvious cause, and the main clinical manifestation is a sudden decrease in hearing, often accompanied by tinnitus, stuffy ears, dizziness and other symptoms. If it is not treated accurately and effectively within the best healing time after the onset of the disease, it is easy to gradually develop into permanent deafness, which greatly increases the mental and psychological pressure on patients.
[0004] There are many methods for treating tinnitus / sudden deafness in modern medicine. Drug treatment is generally adopted. The existing method of treating tinnitus / sudden deafness by acupuncture injection is used alone. However, the efficacy of treating tinnitus / sudden deafness is single and the effect is not obvious. In addition, the injection dosage is not standardized and there is no unified dosage. There is no relevant record of using lidocaine combined with dexamethasone to treat tinnitus / sudden deafness. Summary of the invention
[0005] The purpose of the present invention is to provide a composition for treating sudden deafness or tinnitus and its application. The present invention combines lidocaine and dexamethasone for treating sudden deafness or tinnitus, which can significantly improve the treatment effect.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] The invention provides a composition for treating sudden deafness and / or tinnitus, which is composed of 20 mg / ml lidocaine injection and 5 mg / ml dexamethasone injection in a volume ratio of 0.5:1.
[0008] Preferably, the dexamethasone injection is dexamethasone acetate injection or dexamethasone sodium phosphate injection.
[0009] The present invention also provides the use of the above-mentioned composition in preparing a medicine for treating sudden deafness.
[0010] The present invention also provides application of the above-mentioned composition in preparing medicine for treating tinnitus.
[0011] Preferably, the drug dosage form is an acupoint injection.
[0012] Preferably, the acupoints of the acupoint injection are Tinggong, Jiaosun and Yifeng.
[0013] More preferably, the volume ratio of the drugs used for injection into the Tinggong point, Jiaosun point and Yifeng point is 5:3:7.
[0014] Compared with the prior art, the present invention has the following beneficial effects:
[0015] The present invention provides a composition for treating sudden deafness and / or tinnitus, which is composed of lidocaine injection and dexamethasone injection. The present invention combines lidocaine and dexamethasone for treating sudden deafness and tinnitus, and the two have a synergistic effect, which can improve blood circulation, inhibit impulse input, regulate the auditory system, improve hearing, and alleviate, improve or eliminate tinnitus and sudden deafness. The present invention injects the composition into the Tinggong point, Jiaosun point and Yifeng point by classical acupuncture Hegu acupuncture method, so that the total treatment efficiency of sudden deafness reaches more than 78%, and the total treatment efficiency of tinnitus reaches more than 70%, which significantly improves the treatment efficiency. DETAILED DESCRIPTION
[0016] The invention provides a composition for treating sudden deafness and / or tinnitus, which is composed of 20 mg / ml lidocaine injection and 5 mg / ml dexamethasone injection in a volume ratio of 0.5:1.
[0017] The dexamethasone injection described in the present invention is dexamethasone acetate injection or dexamethasone sodium phosphate injection.
[0018] The specification of the lidocaine injection of the present invention is preferably 5 ml:0.1 g; the specification of the dexamethasone acetate injection is preferably 1 ml:5 mg, and the specification of the dexamethasone sodium phosphate injection is preferably 1 ml:5 mg.
[0019] The present invention has no special limitation on the sources of the lidocaine injection and the dexamethasone acetate injection, and conventional commercial products in the art may be used.
[0020] The lidocaine injection of the present invention has a +The channel produces inhibition, thereby inhibiting the overexcitation of neurons in the auditory conduction pathway reflex arc, blocking the transmission between synapses, thereby inhibiting tinnitus; dilating blood vessels, directly acting on the inner ear microcirculation through the blood-labyrinth barrier, improving the blood circulation of the cochlea and the central nervous system, thereby improving the hypoxia of the spiral ganglion and hair cells, and relieving tinnitus. The dexamethasone acetate injection and dexamethasone sodium phosphate injection are anti-inflammatory drugs with strong anti-inflammatory effects. They can inhibit inflammatory cells, macrophages, etc. to enhance the body's immune response, inhibit the release of inflammatory factors, and reduce the patient's inflammatory response, thereby reducing the patient's tinnitus symptoms. Chemical pump lidocaine and dexamethasone are used in combination to treat sudden deafness and tinnitus. The two have a synergistic effect, which can improve blood circulation, inhibit impulse input, regulate the auditory system, improve hearing, and reduce, improve or eliminate tinnitus or sudden deafness.
[0021] The preparation method of the composition of the present invention preferably comprises: mixing 0.5 ml of lidocaine injection (specification 5 ml: 0.1 g) with 1 ml of dexamethasone injection (specification 1 ml: 5 mg); the dexamethasone injection is dexamethasone acetate injection or dexamethasone sodium phosphate injection.
[0022] The present invention also provides the use of the above-mentioned composition in preparing a medicine for treating sudden deafness.
[0023] The present invention also provides application of the above-mentioned composition in preparing medicine for treating tinnitus.
[0024] The drug dosage form of the present invention is preferably an acupoint injection; the acupoints of the acupoint injection are preferably Tinggong acupoint, Jiaosun acupoint and Yifeng acupoint, and the volume ratio of the drugs used is preferably 5:3:7.
[0025] The present invention inserts the needle through the cranial point to penetrate the tinggong, jiaosun and yifeng points, combining the classical Chinese acupuncture method of Hegu acupuncture (Lingshu Guanzhen says: "Hegu acupuncture is to insert the needle between the left and right chicken feet to remove muscle numbness and the response of the spleen." It belongs to the acupuncture method of "five acupunctures to respond to the five internal organs"). The specific method is: first insert a needle obliquely (or along the skin) into the subcutaneous muscle layer, and then insert a needle at a certain angle to the left and right from the same needle insertion point (i.e., 1 point 3 needles), which is like a chicken foot, once / 2d, two consecutive treatments are separated by 1d, and 6 times are a course of treatment. Through the injection of the acupuncture point behind the ear of the present invention, the drug can be fully diffused in the inner ear, the blood drug concentration can be maintained at a high state, and the drug residence time can be extended.
[0026] The technical solutions in the present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0027] In the following embodiments, unless otherwise specified, all of them are conventional methods.
[0028] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0029] Example 1
[0030] Composition for treating sudden deafness and / or tinnitus
[0031] Mix 0.5 ml of lidocaine injection (specification 5 ml: 0.1 g) and 1 ml of dexamethasone acetate injection (specification 1 ml: 5 mg).
[0032] Example 2
[0033] Composition for treating sudden deafness and / or tinnitus
[0034] Mix 0.5 ml of lidocaine injection (specification 5 ml: 0.1 g) and 1 ml of dexamethasone sodium phosphate injection (specification 1 ml: 5 mg).
[0035] Example 3
[0036] Example 1 Clinical application of the composition in treating sudden deafness
[0037] 1Case Source
[0038] Sichuan Provincial People's Hospital's Department of Otolaryngology and Head and Neck Surgery, Department of Traditional Chinese and Western Medicine Acupuncture, and the Traditional Chinese and Western Medicine Collaborative Specialty Center for Tinnitus, Deafness and Vertigo.
[0039] One hundred patients with sudden deafness who met the case screening criteria and were treated in the outpatient clinics of the Department of Otolaryngology and Head and Neck Surgery, the Department of Traditional Chinese and Western Medicine Acupuncture, and the Specialized Center for Tinnitus, Deafness, and Vertigo of Traditional Chinese and Western Medicine of Sichuan Provincial People's Hospital from October 2023 to May 2024 were selected.
[0040] 2Diagnostic criteria for sudden deafness
[0041] Developed based on the Guidelines for the Diagnosis and Treatment of Sudden Deafness (2015):
[0042] (1) Sudden onset of unexplained sensorineural hearing loss within 72 hours, with a hearing loss of ≥20 dBHL in at least two adjacent frequencies;
[0043] (2) There is no specific age limit for the onset of the disease, and other causes of deafness have been ruled out in the medical history;
[0044] (3) Otological examinations usually show normal eardrum and external auditory canal;
[0045] (4) Hearing impairment and tinnitus may be unilateral or bilateral, intermittent or continuous;
[0046] (5) Hearing examination: pure tone audiometry showed sensorineural hearing impairment;
[0047] (6) Imaging examination: such as temporal bone and brain CT or MRI or X-ray to exclude organic diseases;
[0048] Inclusion criteria
[0049] (1) Meet the above diagnostic criteria;
[0050] (2) No patients with serious heart, brain, kidney or blood system or mental illness;
[0051] (3) Have good compliance;
[0052] (4) Voluntary cessation of other treatments during treatment
[0053] Exclusion criteria
[0054] (1) Those who do not meet the inclusion criteria or are pregnant or lactating women;
[0055] (2) Patients with poor compliance, who do not cooperate with treatment or take medications or accept other treatments during treatment, thus affecting data collection and efficacy evaluation;
[0056] (3) Patients with severe heart, brain, kidney or blood system and mental illness;
[0057] (4) Those with serious adverse reactions or other unexpected situations;
[0058] (5) Tinnitus caused by congenital ear disease, external auditory canal occlusion, middle ear disease, trauma or space-occupying lesions requiring surgical treatment.
[0059] 3 Clinical research methods
[0060] A clinical retrospective study design was adopted, and a treatment group (acupoint injection) and a control group (conventional treatment) were set up, with 50 cases in each group.
[0061] Efficacy observation: Guidelines for the diagnosis and treatment of sudden deafness (2015). Chinese Journal of Otorhinolaryngology Head and Neck Surgery. 2015.50(6):443-447.
[0062] Treatment options:
[0063] Treatment group: acupoint injection, using the classical Hegu acupuncture method of Luxi, 0.7ml of the composition of Example 1 was inserted into the Tinggong, 0.3ml into the Jiaosun, and 0.5ml into the Yifeng, 1 time / 2d, 1d interval between two consecutive treatments, 6 times as a course of treatment, and the efficacy was statistically analyzed after 1 course of treatment.
[0064] Control group: No acupoint injection, treatment according to the standard guidelines for the diagnosis and treatment of sudden deafness, oral administration of prednisone 40 mg once a day, and oral administration of Sanqi Tongshu Capsule (enteric-coated), a drug for improving microcirculation (200 mg / capsule, 1 capsule / time, 3 times / day).
[0065] 4 Observation indicators and efficacy criteria
[0066] Pure tone audiometry refers to the Guidelines for the Diagnosis and Treatment of Sudden Deafness (2015).
[0067] Efficacy criteria:
[0068] Recovery: Hearing at the damaged frequency returns to normal, or reaches the level of a healthy ear, or reaches the level before the illness;
[0069] Significantly effective: hearing loss in the damaged frequency range is improved by more than 30dB on average;
[0070] Effective: The hearing of the damaged frequency is improved by more than 15dB on average;
[0071] Ineffective: The average hearing improvement in the damaged frequency is less than 15dB;
[0072] Note: The efficacy observation indexes were checked once before medication and 14±3 days after treatment, and followed up for 1 month.
[0073] 5 Clinical efficacy evaluation results
[0074] Table 1 Comparison of the efficacy of deafness before and after treatment between the two groups
[0075]
[0076] As shown in Table 1, the total effective rate of the treatment group is 78%, and the total effective rate of the control group is 56%. Compared with the control group, the total effective rate of the acupoint injection of the western medicine composition for treating deafness prepared by the present invention is increased by 22%. The treatment group is better than the control group in hearing improvement, and the difference is statistically significant (P<0.05). Tip: The therapeutic effect of treatment group 1 is significantly better than that of control group 1.
[0077] Example 4
[0078] Example 2 Clinical application of the composition in treating tinnitus
[0079] 1Case Source
[0080] One hundred patients with tinnitus who met the case screening criteria and were treated in the outpatient clinics of the Department of Otolaryngology and Head and Neck Surgery, the Department of Traditional Chinese and Western Medicine Acupuncture, and the Tinnitus, Deafness, and Vertigo Collaborative Specialty Center of Sichuan Provincial People's Hospital from October 2023 to May 2024 were selected.
[0081] 2 Diagnostic criteria for tinnitus
[0082] The diagnostic criteria for tinnitus are based on the 2014 American Tinnitus Clinical Guidelines:
[0083] (1) Tinnitus is the subjective sensation of sound in the ear or head when there is no external sound source;
[0084] (2) There is no specific age limit for the onset of the disease, and other causes of deafness have been ruled out in the medical history;
[0085] (3) Otological examinations usually show normal eardrum and external auditory canal;
[0086] (4) Hearing impairment and tinnitus may be unilateral or bilateral, intermittent or continuous;
[0087] (5) Hearing examination: pure tone audiometry is mostly for sensorineural hearing impairment;
[0088] (6) Imaging examination: such as temporal bone and brain CT or MRI or X-ray to exclude organic diseases;
[0089] Inclusion criteria
[0090] (1) Meet the above diagnostic criteria for tinnitus, with a Tinnitus Handicap Inventory (THI) score ≥ 3;
[0091] (2) No patients with serious heart, brain, kidney or blood system or mental illness;
[0092] (3) Have good compliance;
[0093] (4) Voluntary cessation of other treatments during treatment
[0094] Exclusion criteria
[0095] (1) Those who do not meet the inclusion criteria or are pregnant or lactating women;
[0096] (2) Patients with poor compliance, who do not cooperate with treatment or take medications or accept other treatments during treatment, thus affecting data collection and efficacy evaluation;
[0097] (3) Patients with severe heart, brain, kidney or blood system and mental illness;
[0098] (4) Those with serious adverse reactions or other unexpected situations;
[0099] (5) Tinnitus caused by congenital ear disease, external auditory canal occlusion, middle ear disease, trauma or space-occupying lesions requiring surgical treatment.
[0100] 3 Clinical research methods
[0101] A clinical retrospective study design was adopted, and a treatment group (acupoint injection) and a control group (conventional treatment) were set up, with 50 cases in each group.
[0102] Treatment options:
[0103] Treatment group: acupoint injection, using the classical Hegu acupuncture method of Luxi, 0.7ml of the composition of Example 2 was inserted into the Tinggong, 0.3ml into the Jiaosun, and 0.5ml into the Yifeng, 1 time / 2d, 1d interval between two consecutive treatments, 6 times as a course of treatment, and the efficacy was statistically analyzed after 1 course of treatment.
[0104] Control group: No acupoint injection, treatment according to the 2014 American Tinnitus Clinical Guidelines, dexamethasone 10 mg intravenous drip (once a day), supplemented by microcirculation improving drug Sanqi Tongshu Capsule (enteric-coated) oral administration (200 mg / capsule, 1 capsule / time, 3 times / day).
[0105] 4 Observation indicators and efficacy criteria
[0106] Observation indicators refer to the 2014 American Tinnitus Clinical Guidelines and the Tinnitus Handicap Inventory (THI) score.
[0107] Efficacy criteria:
[0108] Cured: Tinnitus symptoms disappeared;
[0109] Effective: Tinnitus symptoms were alleviated, and the Tinnitus Handicap Inventory (THI) score was reduced by 20 points;
[0110] Uncured: No improvement in symptoms, and the difference in the Tinnitus Handicap Inventory (THI) score is less than 20 points.
[0111] Note: The efficacy observation indexes were checked once before medication and 31±3 days after treatment, and followed up for 1 month.
[0112] 5 Clinical efficacy evaluation results
[0113] Table 2 Comparison of tinnitus efficacy between the two groups before and after treatment
[0114]
[0115] As shown in Table 2, the total effective rate of the treatment group is 72%, and the total effective rate of the control group is 52%. Compared with the control group, the total effective rate of the acupoint injection of the Western medicine composition for treating tinnitus prepared by the present invention is increased by 20%. The treatment group is better than the control group in hearing improvement, and the difference is statistically significant (P<0.05). Tip: The therapeutic effect of the treatment group is significantly better than that of the control group.
[0116] Typical Cases
[0117] 1. Chen Mouqing, female, 36 years old, visited the hospital on May 6, 2024. Chief complaint: left hearing loss for 4+ days.
[0118] Current medical history: 4 days before the consultation, the patient felt that he could not hear anything in his left ear in the morning without any obvious cause, but he did not pay attention to it or take any medicine. Examination: The eardrums of both ears were intact, the marks were clear, and the pure tone audiometry indicated that the high-frequency hearing of the left ear was severely decreased (the hearing threshold was 95). Current symptoms: The hearing of the left ear was significantly decreased, there was no tinnitus or stuffy ears in both ears, no ear pain or ear discharge, no dizziness, dry mouth, bitter and sticky mouth in the morning, chest tightness, yellow urine, dry stool, good appetite, poor sleep, red tongue with yellow greasy coating, and a stringy and slippery pulse. Chinese medicine diagnosis: sudden deafness (liver and gallbladder damp-heat syndrome); Western medicine diagnosis: sudden deafness (left).
[0119] Treatment principle: Clear the liver and reduce fire, clear heat and remove dampness.
[0120] Acupoint injection: Acupoint selection: Luxi, take a 2.5ml syringe, mix 0.5ml of lidocaine injection (specification 5ml: 0.1g) with 1ml of dexamethasone sodium phosphate injection (specification 1ml: 5mg), insert the needle into the periosteum through the Luxi acupoint, penetrate the Tinggong acupoint, Jiaosun acupoint and Yifeng acupoint, the volume ratio of the drugs used for injection is 5:3:7, 1 time / 2d, with 1d interval between two consecutive treatments, and 6 times as a course of treatment.
[0121] Note: After 3 injections behind the ear, the patient felt that his hearing had recovered, but the sound was unclear. After 6 injections, pure tone audiometry showed that the high-frequency hearing in the left ear had returned to normal (25), there was no stuffy or blocked ears, and sleep was normal.
[0122] The patient was a young man with liver-fire inflammation causing dry mouth, bitter taste, yellow urine, dry stool, poor sleep, dampness obstruction, sticky mouth, chest tightness. Combined with the red tongue with yellow greasy coating, and wiry and slippery pulse, it was diagnosed as damp-heat in the liver and gallbladder blocking the ear orifices, and the pathogenesis was true. Dexamethasone is a glucocorticoid with anti-inflammatory effects, and can clear away heat and purge fire, while also exciting the central nervous system. Lidocaine dilates blood vessels and directly acts on the inner ear through the blood-labyrinth barrier. The two are similar to the warm effects of traditional Chinese medicine, warming and unblocking the meridians, activating blood circulation and removing blood stasis, and improving local blood circulation. The Luxi point belongs to the Shaoyang Triple Burner Meridian of the Hand, and has the function of opening the orifices and calming the wind, regulating the triple burner, and allowing damp-heat to exit from the triple burner. Dexamethasone and lidocaine are used together to treat tinnitus and deafness.
[0123] 2. Tang Mouxue, male, 55 years old, visited the hospital on May 8, 2025. Chief complaint: bilateral tinnitus and hearing loss for more than 1 year.
[0124] Current medical history: One year before the consultation, the patient had great work pressure and gradually developed tinnitus, which was aggravated by fatigue and staying up late. The patient had a buzzing tinnitus in both ears, which lasted for a long time, sometimes light and sometimes heavy, and was obvious at night. The patient did not feel that his hearing had decreased, so he was not diagnosed and treated. Current symptoms: bilateral tinnitus, which persists, is slightly heavier on the left side, accompanied by dizziness, stuffy ears, fatigue, affecting mood and sleep, poor diet, unformed stool, pale red tongue, thin white fur, and thin pulse. He had hypertension in the past. The hearing test showed that the eardrums of both ears were intact, the signs were clear, and the pure tone audiometry indicated that the left ear was 50, the right ear was 40, and THI = 3. Chinese medicine diagnosis: tinnitus, sudden deafness (weak spleen and stomach syndrome); Western medicine diagnosis: tinnitus, sudden deafness, and inner ear microcirculation disorder.
[0125] Treatment principle: Strengthen the spleen and replenish qi, raise yang and open the orifices.
[0126] Acupoint injection: Acupoint selection: Luxi, take a 2.5ml syringe, mix 0.5ml of lidocaine injection (specification 5ml: 0.1g) with 1ml of dexamethasone sodium phosphate injection (specification 1ml: 5mg), insert the needle into the periosteum through the Luxi acupoint, penetrate the Tinggong acupoint, Jiaosun acupoint and Yifeng acupoint, the volume ratio of the drugs used for injection is 5:3:7, 1 time / 2d, with 1d interval between two consecutive treatments, and 6 times as a course of treatment.
[0127] Note: After 2 injections behind the ear, the patient felt that the tinnitus had decreased in volume and was only noticeable at night. After 4 injections, the tinnitus was intermittent. After 6 injections, the tinnitus basically disappeared. Pure tone audiometry showed that hearing in both ears returned to normal (hearing threshold less than 25), there was no stuffy ears, dizziness disappeared, and sleep was normal. THI=1.
[0128] The patient is middle-aged, the spleen yang does not rise, the ear orifices are not nourished, resulting in tinnitus, dizziness, stuffy ears, poor sleep, spleen and stomach qi deficiency leading to fatigue, poor appetite, and abnormal bowel movements. Combined with the pale red tongue, thin white fur, and thin pulse, the patient is diagnosed with spleen and stomach weakness, ear orifice malnutrition, and the pathogenesis is deficiency. Dexamethasone is a glucocorticoid that can promote the secretion of gastric acid and pepsin and strengthen the spleen and stomach; lidocaine dilates blood vessels and directly acts on the inner ear through the blood-labyrinth barrier, similar to the warm effect of traditional Chinese medicine, warming the meridians, activating blood circulation and removing blood stasis, improving local blood circulation, and nourishing the ear orifices. Luxi acupoint belongs to the Shaoyang triple burner meridian of the hand, which has the function of clearing the orifices and calming the wind, regulating the triple burner, and smoothing the spleen and stomach functions in the middle burner. Dexamethasone and lidocaine are used together to treat tinnitus and deafness.
[0129] 3. Fu, male, 49 years old, visited the hospital on June 12, 2024. Chief complaint: sudden deafness and tinnitus in the left ear for 1 week.
[0130] Current medical history: One week ago, the patient had sudden deafness in the left ear without obvious cause, accompanied by paroxysmal humming and stuffy ears, which were more obvious at night, and the patient did not receive treatment. The patient had a history of diabetes. The patient now came to our outpatient clinic for further treatment. Physical examination: bilateral tympanic membranes were intact and the landmarks were clear. Pure tone audiometry: The first test showed 85 in the left ear; the test after 3 days showed 25-80-85-90-85-65 in the left ear. THI (tinnitus severity rating scale) = 2. Current symptoms: The patient had sudden deafness in the left ear, accompanied by paroxysmal humming and stuffy ears, and denied ear pain and pus discharge in the ear. Aversion to wind and cold, occasional fever and headache, dry mouth, normal appetite, and good sleep. Red tongue, thin white fur, floating pulse. Chinese medicine diagnosis: sudden deafness (exogenous wind evil syndrome); Western medicine diagnosis: sudden deafness (left).
[0131] Treatment principle: Dispel wind and cold.
[0132] Acupoint injection: Acupoint: Luxi, take a 2.5ml syringe, mix 0.5ml of lidocaine injection (specification 5ml: 0.1g) with 1ml of dexamethasone sodium phosphate injection (specification 1ml: 5mg), insert the needle into the periosteum at Luxi acupoint, and penetrate into Tinggong acupoint, Jiaosun acupoint and Yifeng acupoint. The volume ratio of the drugs used for injection is 5:3:7, 1 time / 2d, with 1d interval between two consecutive treatments, and 6 times as a course of treatment.
[0133] Note: After 1 injection of the acupuncture point behind the ear, the patient felt that the stuffy feeling in the ear was significantly relieved. After 4 injections in a row, the patient felt that the hearing in the left ear was significantly improved and the tinnitus was significantly improved. After 6 injections, the patient felt that the hearing in the left ear returned to normal. The pure tone audiometry test showed that the hearing returned to 30, the stuffy feeling in the ear disappeared, and the tinnitus disappeared.
[0134] The patient is a middle-aged male with high work pressure, long-term headphones, a history of diabetes, and average physical fitness. He likes to stay cool in the air-conditioned room for a long time in the summer, which causes the wind evil to invade the body. At present, he is afraid of wind and cold, occasionally accompanied by fever and headache, dry mouth, and poor appetite. The wind evil blocks the skin surface and then affects the ear orifices. Combined with the tongue and pulse, the syndrome is diagnosed as exogenous wind evil, and the pathogenesis is true. Acupoint injection uses dexamethasone combined with lidocaine. Dexamethasone is a glucocorticoid that has the effects of regulating material metabolism and anti-inflammatory. Lidocaine is an amide local anesthetic. After injection, the tissue distribution is wide and fast, and it can pass through the blood-brain barrier. The combination of the two drugs can better act on the auditory conduction chain such as the cochlea, thalamus, and hippocampus. The Luxi point belongs to the hand Shaoyang triple burner meridian. According to local anatomy, there are posterior auricular arteries and veins, and the anastomotic branches of the great auricular nerve are distributed there. In addition, traditional Chinese medicine believes that the Luxi point has the function of opening the orifices and calming the wind, expelling evil and regulating the triple burner. Dexamethasone and lidocaine can be used together to treat tinnitus and deafness.
[0135] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A composition for treating sudden deafness and / or tinnitus, characterized in that: It is composed of 20mg / 5ml lidocaine injection and 5mg / ml dexamethasone injection in a volume ratio of 0.5:
1.
2. The composition according to claim 1, characterized in that The dexamethasone injection is dexamethasone acetate injection or dexamethasone sodium phosphate injection.
3. Use of the composition according to claim 1 or 2 in the preparation of a drug for treating sudden deafness.
4. Use of the composition according to claim 1 or 2 in the preparation of a drug for treating tinnitus.
5. The use according to claim 3 or 4, characterized in that: The drug dosage form is acupuncture injection.
6. The use according to claim 5, characterized in that: The acupoints of the acupoint injection are Tinggong point, Jiaosun point and Yifeng point.
7. The use according to claim 6, characterized in that: The volume ratio of the medicines used in the Tinggong point, Jiaosun point and Yifeng point is 5:3:7.
